Venous Thromboembolism

Abstract Number: PO188

“Heparin Failure” in Seminoma-related Dramatic Hypercoagulable Melieu and Extended Vein Thrombosis: Is it BEP Protocol Ongoing Responsible?

A.M. Fioretti¹, T. Leopizzi¹, L. Palermo², V. Lorusso², S. Oliva¹

Abstract Number: OC 30.3

CDKN2A Mutational Status is Associated with Venous Thromboembolism in Patients with Glioblastoma

M.Y. Kapteijn¹, F.H. Kaptein¹, M.A. Stals¹, E.E. Klaase¹, R. van Eijk¹, S.C. Cannegieter¹, S.G. van Duinen¹, M.J. Taphoorn¹, L. Dirven¹, J.A. Koekkoek¹, F.A. Klok¹, H.H. Versteeg¹, J.T. Buijs¹

Abstract Number: OC 64.2

25mmHg vs. 35mmHg Elastic Compression Stockings to Prevent Post Thrombotic Syndrome after Deep Vein Thrombosis: The CELEST Double-blind Trial

J.P. Galanaud¹, C. Genty-Vermorel², M.T. Barrellier³, F. Becker⁴, I. Bertaina⁵, S. Blaise⁶, A. Bura Riviere⁷, A. Comte⁶, C. Grange⁸, H. Guenneguez⁹, M. Maufus¹⁰, P. Ouvry⁹, C. Richaud⁶, C. Rolland⁶, J. Schmidt¹¹, M.A. Sevestre¹², F. Verrière⁵, J.-L. Bosson⁶, CELEST Trial Investigators

Abstract Number: OC 25.3

36-month Clinical Outcomes of Patients with Venous Thromboembolism: GARFIELD-VTE

A.G.G. Turpie¹, A.E. Farjat², S. Haas³, W. Ageno⁴, J.I. Weitz⁵, S.Z. Goldhaber⁶, S. Goto⁷, P. Angchaisuksiri⁸, G. Kayani², R.D. Lopes⁹, C.E. Chiang^10,11, H. Gibbs¹², E. Tse¹³, P. Verhamme¹⁴, H. Ten Cate¹⁵, J. Muntaner¹⁶, S. Schellong¹⁷, H. Bounameaux¹⁸, P. Prandoni¹⁹, A.K. Kakkar^2,20

Abstract Number: PB1072

A Comparative Cohort Study of Serum Rivaroxaban Levels in Singaporean (SG) and British (UK) Non-valvular Atrial Fibrillation (NVAF) Patients

E.X. Yong¹, Y.Y. Lin², D. Tan¹, E. Chan¹, V. Speed³, J. Patel³, E.S. Yap⁴, G. Chang², P. Gallagher¹

Abstract Number: PB1073

A Comparison of the Incidence of Traumatic Brain Injury in Anticoagulated and Non-anticoagulated Head Injured Patients

F. Al-Haimus¹, N. Clayton^1,2, J. Klyn², K. de Wit^3,1

Abstract Number: PB1057

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

C. Farkh¹, S. Ellouze¹, L. Gounelle¹, M. Sad-Houari¹, J. Duchemin¹, V. Proulle¹, M. Fontenay^1,2, X. Delavenne^3,4, G. Jourdi^1,5,6,7

Abstract Number: PB1230

A Multi-disciplinary Approach to Improving Temporary IVC Filter Retrieval Rates

J. Kamp¹, T. Ammar¹, J. Wilkins¹, L. Roberts¹

Abstract Number: PB1055

A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis

N. Pozzi¹, V. Pengo²

Abstract Number: PB1121

A Population-Based Descriptive Study of Long-term Anticoagulation in the Treatment and Secondary Prophylaxis of Venous Thromboembolism in Men with Prostate Cancer in Sweden

Y. Balabanova¹, B. Farahmand², P. Stattin³, H. Garmo³, G. Brobert²

Abstract Number: PB1155

A Potential Risk of Venous Thrombosis Induced by Nanomaterials and the Protection Role of Nrf2

Y. Bian^1,2, J. Pi¹

Abstract Number: PB1068

A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus

I. Krichen¹, S. Samet¹, F. Megdich¹, M. Hsairi², L. Gargouri², A. Mahfoudh², C. Kallel¹

Abstract Number: PO165

A Rare Case of Bi-atrial Thrombi in a Stage IV Pancreatic Cancer Patient with Atrial Fibrillation on Warfarin

K.Y. Kim¹, N.H. Kim¹, T. Alrifai²

Abstract Number: PB1256

A Real-world Experience of Venous Thromboembolism (VTE) Management in Australia

B. Lui¹, A. Kwok², J. Lai², Z. Khattak¹, P. Ho¹, H.Y. Lim^1,2

Abstract Number: PB1272

A Realist Evaluation on Therapeutic Elastic Compression Therapy Pathways for DVT- and CVD Patients to Develop Evidence-informed Improvement Strategies

R.H. Schreurs^1,2,3, M.A. Joore⁴, D. De Bruijn-Geraets⁴, H. Ten Cate^1,2,3, A.J. Ten Cate-Hoek^1,2

Abstract Number: PB1249

A Retrospective Evaluation of the Management of Isolated Distal Deep Vein Thrombosis in Australia

B. Lui¹, J. Lai², Z. Khattak¹, A. Kwok², P. Ho¹, H.Y. Lim^1,2

Abstract Number: PB1182

A Simplified Decision Rule to Rule out Deep Vein Thrombosis Using Clinical Assessment and D-dimer

K. Xu¹, K. de Wit^2,3, G.-J. Geersing⁴, T. Takada⁴, R. Schutgens⁴, J. Elf⁵, C. Kearon^2,3, S. Parpia^6,7.

Abstract Number: LB 01.3

A Six-week versus Three-month Duration of Anticoagulation for Acute Provoked Venous Thromboembolism in Patients < 21 Years Old: Results of the Multinational Kids-DOTT Randomized Controlled Trial

N.A. Goldenberg¹,², S. Schulman³, J.M. Kittelson⁴, T.C. Abshire⁵,⁶, M. Bonaca⁴,⁷, J.F. Casella⁸, R.A. Dale⁷, J.L. Halperin⁹, F. Hamblin², C.M. Kessler¹0,¹¹, M.J. Manco-Johnson⁴, R.F. Sidonio¹²,¹³, A.C. Spyropoulos¹⁴,¹⁵,¹⁶, P.G. Steg¹⁷, A.G.G. Turpie³, W.R. Hiatt⁴,⁷, Kids-DOTT Trial Investigators§ and the ATLAS Group

Abstract Number: PB1270

A Survey of Current Anticoagulation Patient Education Practices and Development

A. Jones¹, J. Saunders², S. Vazquez³, A. Fagerlin¹, D. Witt²

Abstract Number: PB1223

A Systematic Review and Meta-analysis on the Use of Chemoprophylaxis in the Prevention of Venous Thromboembolism in Colorectal Cancer Surgery in Asian Population

S.J.J. Tan¹, A.Y. Chok¹, Y.Y. Ng¹, I. Seow-En¹, R. Sultana², J.C. Allen², E.K.W. Tan¹, R. Mathew¹.